Andere talen COSMOS Pharmaceutical Corporation

Aandelen

3349

JP3298400007

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
14.430 ^JPY	-2,27%		+2,78%	-11,39%

12/04	Winst toerekenbaar aan Cosmos Pharmaceutical stijgt met 6,6% in fiscale negen maanden	MT
12/04	COSMOS Pharmaceutical Corporation geeft dividendrichtlijn voor het boekjaar dat eindigt op 31 mei 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	12/04
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	12/04
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores	12/01
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	12/01
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024	12/01
Criptomonedas: Tres temáticas a tener en cuenta	21/12
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores	12-10-23
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023	11-10-23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	11-10-23
OPINIONES DE LOS ANALISTAS DEL DÍA : Santander, Demant, Lufthansa, AXA, BAE Systems, Adidas, GSK, Demant, Just Eat...	08-08-23
Revenez, la semaine n'est pas finie !	08-08-23
AVIS D'ANALYSTES DU JOUR : Saint-Gobain, AXA, Crédit Agricole, Adidas, Demant, Ipsen, Just Eat...	08-08-23
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023	11-07-23
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024	10-07-23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	10-07-23
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings	11-04-23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	10-04-23
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023	10-04-23
AVIS D'ANALYSTES DU JOUR : Airbus, Thales, STMicroelectronics, FDJ, Ubisoft, TF1, Ferrari, Cosmo...	31-01-23
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy	16-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen COSMOS Pharmaceutical Corporation

Aandelen

3349

JP3298400007

Andere talen

Filters